Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Selexis says $2m investment will speed up cell bank delivery time

Cell line developer Selexis has invested in laboratory equipment to reduce delivery times of its high expressing and stable research cell banks.

MilliporeSigma ups single-use mixer volume to 3,000L

MilliporeSigma has launched a new Mobius Power MIX single-use mixing system for buffers, cell culture media powders, and ingredients.

Sanofi using Berkeley Lights’ tech to catalyze cell line development

Berkeley Lights has signed a new agreement with Sanofi through which the company will use its Beacon OptoFluidic Platform to fast-track cell line development.

Cell therapy demand means CMOs need to up their capabilities, PharmSource

There is a lack of third-party capabilities in the autologous cell therapy space says the new editor of PharmSource ahead of this year’s Interphex Convention.

Pall and Artesyn Biosolutions team to industrialize single-use tech

Pall Corporation and Artesyn Biosolutions will co-develop clinical to commercial-scale solutions for single-use automated bioprocessing systems.

Alexion to pay $855m for Swedish biotech with Ph III candidate

Alexion Pharmaceuticals has announced plans to buy Wilson Therapeutics and its lead candidate WTX101, which has received Fast Track designation.

Promotional Features

Content provided by Samsung BioLogics

Samsung BioLogics: The story of the world’s largest biologics manufacturing facility

Samsung BioLogics has moved quickly since it began operating in 2011. The South Korean contract development and manufacturing organization (CDMO) has built a series of progressively larger, more advanced facilities, culminating in its 180,000L “Dream...